Loading...
Sava Healthcare Limited — Dapagliflozin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #15 for Dapagliflozin · $681.6K export value · DGFT Verified
Sava Healthcare Limited is the #15 Indian exporter of Dapagliflozin with $681.6K in export value and 535 verified shipments. Sava Healthcare Limited holds a 1.4% market share in Dapagliflozin exports across 2 countries. The company exports 22 pharmaceutical products worth $11.5M across 11 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| MAURITIUS | $652.6K | 564 | 91.8% |
| SINGAPORE | $58.5K | 7 | 8.2% |
Sava Healthcare Limited exports Dapagliflozin to 2 countries. The largest destination is MAURITIUS accounting for 91.8% of Sava Healthcare Limited's Dapagliflozin shipments. These destinations reflect Sava Healthcare Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| REGENCY PHARMA LIMITED | MAURITIUS | $650.3K | 559 |
| YAMATO TRANSPORT(S)PTE LTD | SINGAPORE | $58.5K | 7 |
| WAREHOUSE NO.1 BPML FREEPORT ZONE | MAURITIUS | $2.3K | 5 |
Sava Healthcare Limited supplies Dapagliflozin to 3 buyers globally. The largest buyer is REGENCY PHARMA LIMITED (MAURITIUS), followed by YAMATO TRANSPORT(S)PTE LTD (SINGAPORE) and WAREHOUSE NO.1 BPML FREEPORT ZONE (MAURITIUS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $34.4M worth of Dapagliflozin through 5,104 shipments from 254 suppliers to 113 countries, serving 502 buyers globally. Sava Healthcare Limited contributes $681.6K to this total, accounting for 1.4% of India's Dapagliflozin exports. Sava Healthcare Limited ships Dapagliflozin to 2 countries through 3 buyers.
Sava Healthcare Limited's average Dapagliflozin shipment value is $1.3K per consignment, based on 535 shipments totaling $681.6K. The largest destination is MAURITIUS (91.8% of Sava Healthcare Limited's Dapagliflozin exports).
Sava Healthcare Limited ranks #15 among 254 Indian Dapagliflozin exporters with a 1.4% market share. The top 3 exporters are MICRO LABS LIMITED ($7.7M), AJANTA PHARMA LIMITED ($5.2M), ALEMBIC PHARMACEUTICALS LIMITED ($4.8M). Sava Healthcare Limited processed 535 shipments to 2 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DAPAVEL 10MG 10 TAB DAPAGLIFLOZIN | $379.0K | 174 |
| DAPARYL 10MG 10 TAB DAPAGLIFLOZIN | $187.2K | 113 |
| DAPAVEL 10MG 10 TAB DAPAGLIFLOZINNOS | $45.3K | 20 |
| DAPARYL 5MG 10 TAB DAPAGLIFLOZIN | $29.7K | 89 |
| DAPARYL 10MG 10 TAB DAPAGLIFLOZINNOS | $17.4K | 20 |
| PHARMACEUTICAL PRODUCT, GLUC-EZ 10,Dapagliflozin tablets 10 mg, PACKS.10 x 10'S | $11.0K | 1 |
| DAPNAT 10MG 100 TAB DAPAGLIFLOZIN | $8.3K | 10 |
| INTAS PHARMACETICALS DAPAGLIFLOZIN | $7.9K | 6 |
| DAPAVEL 5MG 10 TAB DAPAGLIFLOZIN |
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | MSN LABORATORIES PRIVATE LIMITED | $825.0K | 42 | 8 | $19.6K |
| 14 | AUROBINDO PHARMA LTD | $688.9K | 51 | 2 | $13.5K |
| 15 | SAVA HEALTHCARE LIMITED ★ | $681.6K | 535 | 2 | $1.3K |
| 12 | EXEMED PHARMACEUTICALS | $400.0K | 8 | 2 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,003 | 19.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 791 | 15.5% |
| DELHI AIR CARGO ACC (INDEL4) | 761 | 14.9% |
| DELHI AIR | 612 | 12.0% |
| Bombay Air | 194 | 3.8% |
| BANGALORE ACC (INBLR4) | 189 | 3.7% |
| BANGALORE AIR | 160 | 3.1% |
| NHAVA SHEVA SEA (INNSA1) | 136 | 2.7% |
Sava Healthcare Limited also exports these advanced diabetes medications products. Each links to the detailed product page.
Sava Healthcare Limited exports 22 products worth $11.5M. Beyond Dapagliflozin, top products include Ivermectin, Apixaban, Bisoprolol, Fluticasone, Glucosamine. View the complete Sava Healthcare Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Dapagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sava Healthcare Limited's Dapagliflozin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sava Healthcare Limited
Full Company Profile →
22 products · $11.5M total trade · 11 categories
| $7.6K |
| 74 |
| DAPARYL 5MG 10 TAB DAPAGLIFLOZINNOS | $3.7K | 11 |
Sava Healthcare Limited exports 19 distinct Dapagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DAPAVEL 10MG 10 TAB DAPAGLIFLOZIN with 174 shipments worth $379.0K.
| $50.0K |
| 10 | APL HEALTHCARE LIMITED | $300.0K | 6 | 2 | $50.0K |
Sava Healthcare Limited ranks #15 among 254 Indian Dapagliflozin exporters. Average shipment value of $1.3K compared to the market average of $135.5K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and AUROBINDO PHARMA LTD.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 502+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Sava Healthcare Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dapagliflozin. For current shipment-level data, contact TransData Nexus.